This study looked at quantitative and qualitative data from 608 participants who reported extended difficulties following psychedelic experiences.
The most common forms of extended difficulty were feelings of anxiety and fear, existential struggle, social disconnection, depersonalization and derealization.
For approximately one-third of the participants, problems persisted for over a year, and for a sixth, they endured for more than three years.
It was found that a shorter duration of difficulties was predicted by knowledge of dose, drug type and lower levels of difficulty reported during the psychoactive experience, while a narrower range of difficulties was predicted by taking the drug in a guided setting.
Read moreThis recent study shows a striking positive shift in attitudes toward the therapeutic potential of hallucinogens among American psychiatrists since 2016, with a majority of responding psychiatrists planning to incorporate hallucinogen-assisted therapy into their practice if regulatory approval is granted.
Read moreThis recently published study showed that psilocybin use is associated with persisting improvements in mental health and wellbeing.
Read moreA recent study has uncovered evidence pointing to psychedelic use by Neanderthals thousands of years ago.
Strands of human hair found in a Menorca, Spain, burial site gave researchers insight into hallucinogenic use during prehistoric times by some of the earliest species of humans.
Read moreA good article describing how someone who has never had their own psychedelic trip will not be able to guide someone through a trip as intricately as someone who is more experienced.
Even someone who has had a few of their own experiences is limited in their ability to do this.
As a result, the person undergoing treatment with psychedelics is largely left to navigate the unfamiliar landscape by themselves.
This, however, does have some similarities to the shamanic experience.
What do you think?
Read more